Literature DB >> 24361359

Thermal hyperalgesia assessment for rats after spinal cord injury: developing a valid and useful pain index.

Hung Tae Kim1, Taehee Kim1, Brianna Novotny1, Nayab Khan1, James Aksamit1, Steven Siegel1, Gurwattan S Miranpuri1, Daniel K Resnick2.   

Abstract

BACKGROUND CONTEXT: Ongoing research to understand the mechanism behind pain is heavily dependent on animal testing. However, unlike humans, animal subjects cannot directly communicate with researchers to express the degree of pain they are experiencing. Therefore, measuring the presence of pain in animal studies is based on behavioral tests. The use of arbitrary values for determining the presence of pain in animal studies is an oversimplification of a complex and cortically dependent process.
PURPOSE: The purpose of the present study was to identify a statistically supported latency time indicator that can be used as an accurate index for hyperalgesia to thermal stimuli in Sprague-Dawley rats subjected to T9 contusive spinal cord injury (SCI). STUDY
DESIGN: A statistical analysis of latency of withdrawal from stimulus-mediated spinal reflex in 979 Sprague-Dawley rats that had been subjected to a T9 contusive SCI was performed.
METHODS: This is a retrospective review of a large research database derived from a series of studies performed evaluating thermal hyperalgesia in rats after SCI. Sprague-Dawley rats underwent a T9 contusive SCI and were tested for withdrawal latency from a heat stimulus. Assessment was done preinjury and on Postinjury Days 21, 28, 35, and 42 of the chronic phase of injury via a plantar withdrawal test.
RESULTS: The baseline test results of the 979 rats showed a significant resemblance to the normal distribution. The observed change in withdrawal showed mean latency drops of 0.42 second (standard error of the mean [SEM], 0.18; p=.026), 0.57 second (SEM, 0.19; p=.004), 0.63 second (SEM, 0.19; p=.002), and 0.69 second (SEM, 0.19; p=.0003). The standard deviation from the mean at all four postsurgical assessments was between 2.8 and 2.9 seconds.
CONCLUSIONS: Interpretation of withdrawal latency times as a marker for thermal hyperalgesia must be based on an appreciation for the normal distribution of pain scores. Recognizing that withdrawal latency is normally distributed both before and after injury allows for rational assignment of animals to groups designated as hyperalgesic and nonhyperalgesic. Two point nine seconds faster than the mean latency time is a statistically reliable indicator of thermal hyperalgesia in Sprague-Dawley rats subjected to contusive SCI. Repeated testing of animals to establish the presence or absence of thermal hyperalgesia beyond 21 days is not necessary in the absence of intervention.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neuropathic pain; Plantar test; Spinal cord injury; Spinal reflex; Statistical analysis; Thermal hyperalgesia; Withdrawal latency time

Mesh:

Year:  2013        PMID: 24361359     DOI: 10.1016/j.spinee.2013.09.051

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  11 in total

Review 1.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 2.  Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.

Authors:  Dominic Schomberg; Gurwattan Miranpuri; Tyler Duellman; Andrew Crowell; Raghu Vemuganti; Daniel Resnick
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

3.  Use of von Frey filaments to assess nociceptive sensitization in the hornworm, Manduca sexta.

Authors:  Marissa Zubia McMackin; Matthew R Lewin; Dennis R Tabuena; F Eric Arreola; Christopher Moffatt; Megumi Fuse
Journal:  J Neurosci Methods       Date:  2015-10-09       Impact factor: 2.390

4.  Folic Acid Modulates Matrix Metalloproteinase-2 Expression, Alleviates Neuropathic Pain, and Improves Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Gurwattan S Miranpuri; Sivan Vadakkadath Meethal; Emmanuel Sampene; Abhishek Chopra; Seah Buttar; Carrie Nacht; Neydis Moreno; Kush Patel; Lisa Liu; Anupama Singh; Chandra K Singh; Nithya Hariharan; Bermans Iskandar; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2017-05-12

Review 5.  Implication of Hypothalamus in Alleviating Spinal Cord Injury-Induced Neuropathic Pain.

Authors:  Andrew D Crowell; Kevin King; Annika Deitermann; Gurwattan S Miranpuri; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2016-09-09

6.  Role of Matrix Metalloproteinases 2 in Spinal Cord Injury-Induced Neuropathic Pain.

Authors:  Gurwattan S Miranpuri; Dominic T Schomberg; Bahauddeen Alrfaei; Kevin C King; Bryan Rynearson; Vishwas S Wesley; Nayab Khan; Kristen Obiakor; Umadevi V Wesley; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2016-03-11

7.  Compression of The Sciatic Nerve May not Contribute to Ipsilateral Hyperalgesia Development in Ovariectomized Female Rats!

Authors:  Nafissa Telailia; Sylvain Fisson; Hacène Frih
Journal:  Cell J       Date:  2020-04-22       Impact factor: 2.479

8.  Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1.

Authors:  Mostafa M Ahmed; HyunKyung Lee; Zach Clark; Gurwattan S Miranpuri; Carrie Nacht; Kush Patel; Lisa Liu; Jiliian Joslin; Douglus Kintner; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2014-07

9.  Folic Acid Modulates Matrix Metalloproteinase-9 Expression Following Spinal Cord Injury.

Authors:  Gurwattan S Miranpuri; Justyn Nguyen; Neydis Moreno; Noemi A Yutuc; Jason Kim; Seah Buttar; Greta R Brown; Sydney E Sauer; Chandra K Singh; Saurabh Kumar; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2019-04-01

Review 10.  Yoga: Can it be integrated with treatment of neuropathic pain?

Authors:  Shirley Telles; Natasha Sayal; Carrie Nacht; Abhishek Chopra; Kush Patel; Alice Wnuk; Priya Dalvi; Kulsajan Bhatia; Gurwattan Miranpuri; Akshay Anand
Journal:  Ann Neurosci       Date:  2019-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.